{"id":1365,"date":"2014-02-01T00:00:32","date_gmt":"2014-02-01T05:00:32","guid":{"rendered":"http:\/\/rhochistj.org\/RhoChiPost\/?p=1365"},"modified":"2014-12-05T20:17:37","modified_gmt":"2014-12-06T01:17:37","slug":"increasing-roles-pharmacists-transplant-outcomes","status":"publish","type":"post","link":"https:\/\/rhochistj.org\/RhoChiPost\/increasing-roles-pharmacists-transplant-outcomes\/","title":{"rendered":"The Increasing Roles of Pharmacists in Transplant Outcomes"},"content":{"rendered":"<p><span style=\"font-size: 11pt; line-height: 1.5em;\">By: Jenny Park, PharmD Candidate c\/o 2015<\/span><\/p>\n<p>&#8211;<\/p>\n<p>Medication adherence is a big part of a patient\u2019s success in managing their health conditions. The Annals of Internal Medicine estimated that the cost of medication non-adherence may reach up to $289 billion each year.<sup>1 <\/sup>It is crucial for organ transplant patients to take powerful immunosuppressants to help overcome the body\u2019s response of the newly transplanted organ, but non-adherence remains to be a roadblock. According to Brett Sahli, PharmD, who is a manager at the pharmacy benefit manager (PBM) OptumRx, non-adherence rates among the transplant population are anywhere from 20% to 70%. This is problematic because \u201cmissing just a couple of days can cause rejection\u201d of a transplanted organ.<sup>3<\/sup><\/p>\n<p>Many patients may stop taking their medications because of the undesirable side effects or because they don\u2019t realize the importance of taking their medications. OptumRx and United Health Care have been setting up specialty pharmacies that focus on patient education in addition to dispensing medications. &#8220;We&#8217;ve seen similar outcomes in improving medication adherence and clinical results and lowering medical service costs through our specialty pharmacy programs in oral oncology, rheumatoid arthritis, and multiple sclerosis,&#8221; said lead author and vice president Suzanne Tschida, PharmD, BCPS.<sup>2 <\/sup>Some PBMs have implemented a \u201ctotal care management\u201d in study models to address how the patient feels in addition to the traditional drug management. This holistic approach to therapy engages and empowers patients to manage their medications and take ownership. In addition, patients who actively manage their medications are more likely to make better health decisions.<sup>1 <\/sup><\/p>\n<p>OptumRx and United Health Care conducted a study that compares post transplant patient care in specialty pharmacies and in retail pharmacies. The difference between the two groups in outcome was statistically significant. The group receiving care from the specialty pharmacy was associated with lower transplant related medical costs, lower overall health care costs, and most importantly, higher medication adherence. There was a 30% reduction in transplant related medical costs and a 13% reduction in overall health care costs for the duration of the study, and medical costs associated with using a specialty pharmacy were $5960, whereas the costs for a retail pharmacy was $8486.<sup>2<\/sup> Transplant specialty pharmacists provide people with adherence and clinical management programs. They also provide patients with education and counseling services. The goals, said Tschida, were to \u201creduce variability in pharmaceutical care, promote medication adherence and help members\u201d manage side effects so they can continue taking immunosuppressants, resulting in \u201cbetter outcomes and lower health care costs.\u201d<sup>3 <\/sup>Through patient education, specialty pharmacists can help patients optimize their therapy and reduce healthcare costs.<\/p>\n<p>Many patients in general need help understanding their medication regimens and need to be given specific directions. Patients may have difficulty understanding how and when to take their medications, and what their medications interact with. For instance, many patients do not understand that taking their medication \u201ctwice a day\u201d means every twelve hours, or why drinking milk with certain antibiotics is \u201cbad\u201d. This leads to non-adherence which may prevent the treatment from reaching its maximum potential. With the help of pharmacists who specialize in their respective fields, patients will have improved health outcomes through close monitoring and education.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">SOURCES:<\/span><\/strong><\/p>\n<ol>\n<li>Tschida S Improving transplant care outcomes. Specialty pharmacy times website. January 2, 2014. <a href=\"http:\/\/www.specialtypharmacytimes.com\/publications\/specialty-pharmacy-times\/2013\/Sept_Oct-2013\/Improving-Transplant-Care-Outcomes\" target=\"new\" class=\"external external_icon\">http:\/\/www.specialtypharmacytimes.com\/publications\/specialty-pharmacy-times\/2013\/Sept_Oct-2013\/Improving-Transplant-Care-Outcomes.<\/a> Accessed January 2,2014.<\/li>\n<li>United Health care group. Optum Study Documents Pivotal Role Specialty Pharmacy Plays in Improving Health Care Outcomes, Lowering Cost. January 2, 2014. <a href=\"http:\/\/www.unitedhealthgroup.com\/Newsroom\/Articles\/Feed\/Optum\/2013\/0627SpecialtyPharmacy.aspx\" target=\"new\" class=\"external external_icon\">http:\/\/www.unitedhealthgroup.com\/Newsroom\/Articles\/Feed\/Optum\/2013\/0627SpecialtyPharmacy.aspx.<\/a> Accessed January 2, 2014<\/li>\n<li>Maas, A. Specialty pharmacy program can improve kidney transplant patient. AIS health website. January 2, 2014. <a href=\"http:\/\/aishealth.com\/archive\/nspn0913-02\" target=\"new\" class=\"external external_icon\">http:\/\/aishealth.com\/archive\/nspn0913-02.<\/a> Accessed January 2, 2014<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>By: Jenny Park, PharmD Candidate c\/o 2015 &#8211; Medication adherence is a big part of a patient\u2019s success in managing their health conditions. The Annals of Internal Medicine estimated that the cost of medication non-adherence may reach up to $289 billion each year.1 It is crucial for organ transplant patients to take powerful immunosuppressants to&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,5],"tags":[343,192,13,2227,314,20,93,2235,14,363,1625,657,45,19,2230,11,1820,187,21,1161,16,1061],"class_list":["post-1365","post","type-post","status-publish","format-standard","hentry","category-featured","category-news-politics","tag-and","tag-annals","tag-drug","tag-ebola-virus-disease","tag-for","tag-health","tag-january","tag-kidney","tag-medication","tag-of","tag-or","tag-oral","tag-organ","tag-patient","tag-pharmaceutical","tag-pharmacy","tag-reduction","tag-side","tag-study","tag-therapy","tag-treatment","tag-with"],"views":967,"_links":{"self":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/posts\/1365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/comments?post=1365"}],"version-history":[{"count":0,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/posts\/1365\/revisions"}],"wp:attachment":[{"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/media?parent=1365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/categories?post=1365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rhochistj.org\/RhoChiPost\/wp-json\/wp\/v2\/tags?post=1365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}